GlassScriptPhysician profile
Julia M Degler
NPI 1295996346
$3,133.04
in general payments reported to CMS, 2019-2025
38 companies · $522 in 2025
The $522 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $940 · 2020: $50.69 · 2022: $275 · 2023: $628 · 2024: $717 · 2025: $522.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,867.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,866.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $424.37 | 2022-2025 | Vraylar, Linzess, Viberzi |
| Lilly USA, LLC | $332.00 | 2019-2024 | Jardiance, Mounjaro, Zepbound |
| Novo Nordisk INC | $299.06 | 2019-2025 | Ozempic, Rybelsus |
| Novartis Pharmaceuticals Corporation | $209.25 | 2019-2025 | |
| Glaxosmithkline, LLC. | $208.22 | 2019-2025 | Shingrix, Arexvy, Trelegy Ellipta |
| Astellas Pharma US INC | $200.74 | 2019-2025 | Veozah |
| Pfizer INC. | $199.54 | 2019-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $189.75 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $147.32 | 2019-2024 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $107.67 | 2019-2025 | Farxiga, Breztri |
| Phathom Pharmaceuticals, INC. | $93.99 | 2023-2025 | Voquezna |
| Amarin Pharma, INC. | $74.18 | 2019 | |
| Exact Sciences Corporation | $68.77 | 2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Takeda Pharmaceuticals U.S.A., INC. | $66.19 | 2019-2025 | Trintellix |
| Bayer Healthcare Pharmaceuticals INC. | $43.43 | 2022-2024 |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julia Degler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.